Philip J. Rosenthal MD
 https://profiles.ucsf.edu/philip.j.rosenthal Neutropenia in cancer patients receiving myelosuppressive chemotherapy Authorization of 6 months may be granted for prevention or treatment of febrile neutropenia when both of the following criteria are met: 1 chronic gastritis medicine cheap 20mg bentyl visa. Member has a non-myeloid malignancy and has received gastritis diet tomatoes buy 20mg bentyl mastercard, is currentlyreceiving gastritis dieta recomendada discount bentyl express, or will be receiving myelosuppressive anti-cancer therapy 2 gastritis symptoms vs. heart attack order genuine bentyl. The requested drug will not be administered less than 24 hours before or after chemotherapy or radiotherapy B. Other indications Authorization of 6 months may be granted for members with any of the following indications: 1. Patients who are inoperable by performance status or comorbidity, or have local disease or local disease with minimal extrahepatic disease only c. Subsequent treatment as a single-agent for patients who have progressed after first-line lenvatinib 2. A component of repeating the initial successful induction if late relapse (greater than or equal to 12 months) for relapsed or refractory disease d. In combination with azacitidine or decitabine for relapsed or refractory disease 3. Desmoid tumors (aggressive fibromatosis), primary, recurrent, or progressive disease c. Thyroid carcinoma (medullary carcinoma, papillary carcinoma, Hurthle cell carcinoma, or follicular) 6. Relapsed/refractory bone cancer, as second-line therapy as a single agent for the following subtypes: a. Epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer; if platinum-resistant, in combination with topotecan for persistent disease or recurrence All other indications are considered experimental/investigational and are not a covered benefit. Authorization of 12 months may be granted for treatment of unresectable or metastatic hepatocellular carcinoma. Authorization of 12 months may be granted for treatment of hepatocellular carcinoma for subsequent treatment as a single agent for members who progressed after first-line lenvatinib. Acute Myeloid Leukemia Authorization of 12 months may be granted for treatment of acute myeloid leukemia when either of the following criteria are met: 1. Authorization of 12 months may be granted for treatment of angiosarcoma, solitary fibrous tumor, or hemangiopericytoma as single agent therapy. Authorization of 12 months may be granted for treatment of primary, recurrent, or progressive desmoid tumor/aggressive fibromatosis. Renal Cell Carcinoma Authorization of 12 months may be granted for treatment of advanced renal cell carcinoma. Differentiated Thyroid Carcinoma Authorization of 12 months may be granted for treatment of progressive and/or symptomatic radioiodine refractory papillary, Hurthle cell, or follicular thyroid carcinoma. Medullary Thyroid Carcinoma Authorization of 12 months may be granted for treatment of medullary thyroid carcinoma when either of the following criteria are met: 1. Member has disease progression while on vandetanib (Caprelsa) or cabozantinib (Cometriq). Authorization of 12 months may be granted for treatment as second-line therapy for relapsed/refractory or metastatic disease as a single agent for the following types of bone cancer: a. Chordoma Authorization of 12 months may be granted for treatment of recurrent chordoma as a single agent. Epithelial Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Authorization of 12 months may be granted for treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer if the disease is platinum-resistant and Nexavar is given in combination with topotecan for persistent disease or recurrence. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study. Indicated for the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease. Indicated for long-term maintenance therapy in acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option. Indicated for long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors. Meningiomas Authorization of 24 months may be granted to members for treatment of unresectable meningioma. Thymomas and thymic carcinomas Authorization of 24 months may be granted for treatment of thymomas and thymic carcinomas. American Association of Clinical Endocrinologists Acromegaly Guidelines Task Force. All other indications are considered experimental/investigational and are not a covered benefit. Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet before receiving Epanova and should continue this diet during treatment with Epanova. Laboratory studies should be done to ascertain that the triglyceride levels are consistently abnormal before instituting Epanova therapy. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. Limitations of Use the effect of Epanova on the risk for pancreatitis has not been determined. The effect of Epanova on cardiovascular mortality and morbidity has not been determined. Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet before receiving Lovaza and should continue this diet during treatment with Lovaza. Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting Lovaza therapy. Medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. Limitations of Use the effect of Lovaza on the risk for pancreatitis has not been determined. The effect of Lovaza on cardiovascular mortality and morbidity has not been determined. Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet and exercise regimen before receiving Vascepa and should continue this diet and exercise regimen with Vascepa. Attempts should be made to control any medical problems such as diabetes mellitus, hypothyroidism, and alcohol intake that may contribute to lipid abnormalities. Limitations of Use the effect of Vascepa on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. The effect of Vascepa on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined. Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Extranodal natural killer/T-cell lymphoma, nasal type: as a component of multi-agent chemotherapeutic regimen 2. Extranodal Natural Killer/T-cell Lymphoma, nasal type Authorization of 12 months may be granted for the treatment of extranodal natural killer/T-cell lymphoma, nasal type when the requested medication is used in conjunction with multi-agent chemotherapy. Moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age orolder 3. Active psoriatic arthritis in adults All other indications are considered experimental/investigational and are not a covered benefit. Member has experienced an inadequate response to at least a 3-month trial ofmethotrexate despite adequate dosing. Authorization of 24 months may be granted for members who have previously received Orencia or Actemra. Pediatric pulmonary hypertension: guidelines from the AmericanHeart Association and American Thoracic Society. Authorization of 24 months may be granted for treatment of moderate to severe plaque psoriasis when all of the following criteria are met: 1. Member has a clinical reason to avoid pharmacologic treatment with methotrexate, cyclosporine or acitretin (see Appendix A). Appendix A: Examples of Clinical Reasons to Avoid Pharmacologic Treatment with Methotrexate, Cyclosporine or Acitretin. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendation for psoriatic arthritis.
Martinez Linz gastritis kidney pain cheap bentyl american express, Linz diet during gastritis attack buy 20 mg bentyl with amex, Austria; 4Wilmer Eye Institute 7 day gastritis diet generic 20mg bentyl with amex, Johns Vitelliform Maculopathy in Reticular Drusen gastritis diet óêðçàë³çíèöÿ cheap bentyl 20 mg on line. Ophthal and reduces apoptosis of human uveal melanoma Referral Center in United Kingdom. Anastasia and Neurobio-Childrens Hosp, Washington Univ cells by activating Wnt/catenin signaling Tasiopoulou1, 2, M. Unigarro Martinez, Ophthalmology and Optometry, Wenzhou Medical Translational 2 S. Xerencia de Xestion Integrada hepatic stellate cells by uveal melanoma cells Flow Regulation in Patients with Primary Open de Santiago de Compostela, Santiago de 1, 2 1, 2 1 2 in a xenograft mouse model. Petaccia de Medicine and Pharmacy, Bucharest, Romania; 2 1 3 4 a predictive biomarker for metastatic uveal 6 Macedo, J. Zin, 1 Vienna, Vienna, Austria f 1 1 1 Department of Pathology, Rigshospitalet, A. Ophthalmology/ Hamilton Eye peripapillary capillaries and macular capillary Laser Speckle Flowgraphy. Asahikawa Medical University, Asahikawa, and Biochemistry, University of Tennessee Health 2 1 1 3 K. Department of Surgical Sciences, Eye Clinic, University of Southern California Roski Eye Patterson2, J. Waheed and Deeba Husain Ophthalmology, Columbia University, New York, Tomography Angiography Images. Experimental Eye Research Institute, 2 1 2 1 1 Ophthalmology, David Geffen School of Medicine T. Ophthalmology, Johns Ophthalmology, John P Hussman Institute for 1, 2 1 2 Future Use. Kingdom; 2University College London, London, in the mouse non-arteritic anterior ischemic Valgerdur D. Meriam therapy: Evaluation of a new quantitative 3 3 3 2 1 1, 2 1, 3 1, 3 1 1 1 K. Coherence Tomography Angiography: 1, 2 2 2 Neovascularization in Patients with Unilateral Lisa Yun, M. Associations with chronicity and treatment 2 1 2, 3 1, 3 Exudative Age-Related Macular Degeneration Hubschman. Drusen in Non-Exudative Age-related Macular 2 1 2 Bioengineering, University of Washington, Seattle, Nadal, M. Hospital Wurzburg, Wurzberg, Germany; 4Mount London, United Kingdom; 2Department of surgery Choovuthayakorn1, N. Yukinori Image Analysis Laboratory, Doheny Eye subretinal visualization using an ophthalmic Sugano, A. Department of Ophthalmology 4 1 4 Community Healthcare Organization Chukyo Vupparaboina, G. University of Tsukuba, Policlinico, University of Milan, Milan, Italy; L V predict future growth rate. Grossenbacher, Republic of); Mechanical Engineering, Korea 1 1 2 Johns Hopkins University School of Medicine, L. Tytteli Turunen, Pediatric Oncology, Utrecht, Netherlands; 4Erasmus Tokyo, Japan; 6School of Medicine, Sungkyunkwan M. Rahimi-Oztan, 2 2 1 1 1 Physics, Faculty of Sciences, the University of Korea (the Republic of); Division of Bio-Medical N. He, 2 Singapore; Singapore Eye Research Institute, Contributes to Corneal Epitheliopathy in Tear T. Christine Xiamen, Fujian, China Environmental Life Sciences Engineering, Nanyang Mun, S. University of New South Wales, Sydney, New South Ophthalmology & Visual Sciences, University of Sharma. Madrid, Spain; 2Sanitary Research Institute of the Moderators: Sunil Chauhan and Daniel R. Okumura1, Kingdom; Optics and Optometry, Complutense agents on the Tear and Ocular Surface: a mucin T. Schneider1, by infuencing both neutrophils and endothelial to Prolong Corneal Allograft Survival. University of New South Wales, Sydney, New South in the Setting of Regulatory T cell Dysfunction. Department of Ophthalmology, Baylor College Service, New England Eye Center, Department 1St. Buttner2, Eye Research Institute, Massachusetts Eye and Ear 3Departments of Cell Biology, Ophthalmology and T. Oregon Health and Science University, Portland, 1 1 2 1 Tomography Findings in Experimental Anterior 2 Yanhong Hou, V. Correlation with retinal nerve Germany; 2Institute for Transfusion Medicine, Eye Movements/Strabismus/Amblyopia/Neuro fber layer and visual feld loss. Matsumoto6, Metropolitan Institute of Medical Science, Tokyo, Human and Murine Corneal Neovascularization. Ophthalmology, Wakayama Medical (Bregs) in the pathogenesis of idiopathic optic University, Wakayama, Wakayama, Japan Research and Education, Hyogo College of neuritis. Klistorner, infltration and axonal damage in the mouse 7 1, 2 1 Scienze Neurologiche, Universita di Bologna, S. Bentyl 20 mg without prescription. An 8-year-old dog vomits for 5 days - gastritis.
It is challenging gastritis diet ïî÷òà purchase 20mg bentyl with visa, but certainly not impossible gastritis diet ÷àò order bentyl 20 mg, for women to maintain a thriving professional career and have children gastritis symptoms medication cheap 20 mg bentyl mastercard. Certain specialties more easily allow for maternity leave and time to raise children diet with gastritis recipes 20mg bentyl overnight delivery, particularly during the peak reproductive years surrounding resi dency training and initial employment. In a survey of women who entered pedi atrics, for example, nearly half based the timing of pregnancy on their career stage, leading to a mean age of conception at 29 years (when most were just out of residency). Take a closer look at whether physicians in your chosen specialty might penalize female physicians for maternity leaves or even actively discourage their pregnancies. For instance, hospital-based specialties such as radiology, anesthesiology, and emergency med icine offer more predictable schedules, ones in which you will rarely take work home with you. Unlike the trauma surgeon, gastroenterologist, or obstetrician, physicians in areas like psychiatry and dermatology seldom get paged for emer gencies in the middle of the night. These are all areas of medicine that might be more amenable to exibility when it comes to timing a pregnancy. For most women, stability within their specialty is just one of many factors that play a part in their happiness in medicine. In the workplace, female physi cians often have to cope with sexual harassment, higher expectations, and salary inequity. In general, women in medicine earn less money than men because more are either clustered within the lower-paying primary care specialties or work part time. Moreover, women have to tackle an inverted career pyramid, one in which they will devote more time to their careers only after bearing and raising children at a younger age. Most specialties are exible enough to allow women physicians to have an outside family life and to raise children. The rig orous, sleep-deprived lifestyle of surgery, however, requires the greatest time commitment, particularly when it comes to the intensity and length of residency training. Partly because of this, surgery has traditionally been a rather male-dom inated eld. Initially, just like their male colleagues, many female medical students do nd themselves attracted to a career in surgery. They are partial to the emphasis on technical procedures, the ability to save a patients life, and the immediate grati cation of performing a surgical operation. They love the thrill of delving into the internal anatomy of a fellow human being. They could actually see them selves becoming orthopedic surgeons, cardiothoracic surgeons, or surgical on cologists. Yet there is still a striking underrepresentation of women in the surgi cal specialties. Why do 76% of women who plan to pursue surgery lose their interest and commit to something else It is clear that certain barriers within the surgical profession end up discour aging women from entering. Many women are discouraged by the long hours, fam ily sacri ces, and male-dominated operating room. Also, performing routine and emergency surgery on patients at all hours of the day and night does not lend itself well to being an available parent. Compared to other specialists, female surgeons are more likely to be single (but their divorce rate is equal to that of their male col leagues). And, because of strong professional aspirations and interests, they are also less likely than others to have children, or, if they do, more likely to have full-time childcare. Clearly, there are many variables that every potential female surgeon should think about carefully when considering a surgical career. Surgery is the one specialty where female doctors have the most difficulty in tegrating themselves with their male colleagues. General surgery, orthopedics, and neurosurgery are competing for these female applicants, all of whom are no longer discouraged by the rigorous training of the competitive tiers of medicine. As a way of helping their fellow women, many female medical students now aspire to become breast surgeons. Despite the drastically skewed distribution of men to women, nearly all (94%) of female urologists would highly encourage other women to enter this boys club specialty. In the primary care specialties, like pediatrics and family practice, female doctors have successfully led the way for innovative practice options, like working part time or job sharing. Other spe cialties, however, have been slow to accept the following more accommodating career strategies. Practicing Medicine Part Time By de nition, working fewer than 40 hours per week is considered part time. Specialties with highly controllable hours are also as conducive, such as the shift work of emergency medicine, the case-by-case nature of anesthesiology, the scheduled hours of pathology and radiology, and the lack of off-hour emergencies in dermatology and ophthalmology. Breast surgeons, for instance, perform mainly elective surgery and can therefore schedule fewer cases and less clinic time each week. Another way to work part time is to arrange for a shared-schedule position with another physician. In this format, each doctor works half time with alternating appointment schedules; together, they equal one practitioner. Some even arrange this system with their spouse if both are in the same specialty. In either situation, remember that working part time means sacri cing higher salaries for exibility. Another disadvantage is that part-time academic physicians are ineligible for tenure, and those in private practice often are unable to become partners or stock holders in the practice. Women should also keep in mind that many unsympa thetic colleagues may be hostile to physicians seeking to change their schedules to ful ll parental roles. Work Out of Your Home Many female solo practitioners, particularly those in psychiatry, opt to set up their office in their home. The major disadvantage, of course, is the intrusion of patients, secretaries, nurses, and other staff members on your home property. Enter Academics Rather Than Becoming a Private Practitioner In the university teaching hospital, academic physicians devote less clinical time. You will have greater job exibility in this salaried position because of the additional time for teaching and research. Unlike private practice, there is much less emphasis in academic medicine on productivity and seeing as many patients as possible. In fact, female physicians practicing in medical schools and teaching hospitals reported the most happiness with their specialty choice. Seeking advice from a respected faculty member is an essential part of choosing a specialty; form these relationships early in your medical training. Because women often have addi tional concerns when deciding on their specialty, a good female mentor can pro vide invaluable guidance. Remember, you do not have to establish an advisor advisee relationship with lots of physicians, or even with ones who practice in the specialty under consideration. More importantly, female medical students should seek out other women who have already gone through the same decisions. These doctors usually have a wealth of information and personal experience about be ing female in a male-dominated profession. They should be more than happy to share their thoughts and answer questions from a younger version of themselves. The best female mentor makes you feel comfortable enough to exchange ideas, personal thoughts, and concerns. She should always make herself avail able for discussing somewhat intimate issues, such as marriage, gender discrim ination, career aspirations, and the best time to have children.
It is accordingly still at its very earliest stages gastritis diet in dogs buy generic bentyl from india, and the record is necessarily limited gastritis diet 02 cheap bentyl 20mg line. The Court is persuaded that Plaintiffs have made these fairly modest showings gastritis meal plan trusted 20 mg bentyl, but this is not a final adjudication of the merits of Plaintiffs claims gastritis meaning buy bentyl 20 mg on line. Irreparable Injury Next, the Court finds that Plaintiffs have demonstrated that they would suffer irreparable injury in the absence of preliminary injunctive relief. In order to satisfy the irreparable injury requirement, [f]irst, the injury with must be both certain and great; it must be actual and not theoretical. Defendants argue that for much the same reasons they lack standing, Plaintiffs cannot show that they will suffer certain, great, or any actual injuries if the Court does not enter an injunction. The Court has already rejected those arguments in the context of finding that Plaintiffs have standing, at least with respect to the Accession and Retention Directives, and rejects them again in this context. Absent an injunction, Plaintiffs will suffer a number of harms that cannot be remediated after that fact even if Plaintiffs were to eventually succeed in this lawsuit. The impending ban brands and stigmatizes Plaintiffs as less capable of serving in the military, reduces their stature among their peers and officers, stunts the growth of their careers, and threatens to derail their chosen calling or access to unique educational opportunities. Money damages or other corrective forms of relief will not be able to fully remediate these injuries once they occur. Moreover, these injuries are also imminent, in that they are either ongoing or, at the latest, will begin when the Accession and Retention Directives take effect early next year. These injuries are irreparable for the additional reason that they are the result of alleged violations of Plaintiffs rights to equal protection of the laws under the Fifth Amendment. Under this line of authority, Plaintiffs allegation of constitutional injury is sufficient to satisfy the irreparable injury requirement for issuance of a preliminary injunction. Balance of Equities and Public Interest Finally, the Court finds that Plaintiffs have shown that the public interest and the balance of hardships weigh in favor of granting injunctive relief. As already established, the Presidential Memorandum is causing Plaintiffs serious ongoing harms and will cause them further harms in the near future absent an injunction. On this record, there are no countervailing equities or public interest in precluding transgender service members from the military that outweigh those harms. A bare invocation of national defense simply cannot defeat every motion for preliminary injunction that touches on the military. On the record before the Court, there is absolutely no support for the claim that the ongoing service of transgender people would have any negative effective on the military at all. In fact, there is considerable evidence that it is the discharge and banning of such individuals that would have such effects. The Court also notes that fifteen States have filed an amici brief indicating that they and their residents will be harmed by the Presidential Memorandum if it is not enjoined. Moreover, the injunction that will be issued will in no way prevent the government from conducting studies or gathering advice or recommendations on transgender service. The balance of equities and public interest accordingly weigh in favor of granting Plaintiffs motion. The Court will grant Defendants motion to dismiss Plaintiffs claims to the extent they are based on the Sex Reassignment Surgery Directive, as well as Plaintiffs estoppel claim. The Court will grant Defendants motion to dismiss Plaintiffs claims to the extent they are based on the Sex Reassignment Surgery Directive, corresponding with section 2(b) of the Presidential Memorandum, as well as Plaintiffs estoppel claim. The Secretary of Defense, and the Secretary of Homeland Security with respect to the U. This is a constitutional challenge to the ban on military service by transgender individuals (transgender military ban or ban). That policy, first announced last July by 1 the parties agreed to the dismissal of the claims brought by Jane Doe 1, who is no longer in the Armed Forces. Mattis (February 22 Memorandum), excludes transgender people from military service, regardless of their fitness to serve. The transgender military ban, as originally articulated in tweets from the President and as set forth in the February 22 Memorandum, inflicts immediate, concrete injury upon Plaintiffs. It violates both the Equal Protection component of the Fifth Amendment and the Due Process Clause of the Fifth Amendment to the United States Constitution. This lawsuit seeks declaratory, preliminary, and permanent injunctive relief against implementation of the ban. Plaintiffs are five active duty servicemembers in the United States military who serve openly as transgender people; one active duty servicemember who has not yet disclosed her transgender status; and four transgender people who seek admission to the military, either through the process of enlistment or through an academic program that leads to a commission. Some proceed under pseudonyms here to protect their privacy and for fear of retribution. Jane Doe 2 has been enlisted in the National Guard since 2003 and has been on active duty in the United States Army since 2006. Jane Doe 2 notified her command that she was transgender after the United States Department of Defense announced in June 2016 that it would allow transgender servicemembers to serve openly in the military. Since informing her command that she is transgender, Jane Doe 2 has continued serving in her post without incident. Under the transgender military ban, she will be forced to serve under a cloud of uncertainty about continued service, promotions, and health care; and she will suffer harm because her continued service will be permitted only under a conditional and limited exception to a policy that deems transgender people unfit for service. She has previously been deployed to Afghanistan and is currently deployed to Iraq. In or around June 2016, in reliance on the Department of Defense policy permitting transgender people to serve openly in the military, Jane Doe 3 notified her command that she was transgender. She plans to renew her contract and is also interested in applying to become a warrant officer or making other career transitions that could be considered a new accession to the Army. Under the transgender military ban, it is unclear whether Jane Doe 3 will be able to make these career transitions. At a minimum, she will be forced to serve under a cloud of uncertainty about continued service and health care; and she will suffer harm because her continued service will be permitted only under a conditional and limited exception to a policy that deems transgender people unfit for service. In or around June 2016, in reliance on the Department of Defense policy permitting transgender people to serve openly in the military, Jane Doe 4 met with her commanding officer to identify herself as transgender. She began receiving medical treatment related to her gender transition in September 2016. Since coming out as transgender, Jane Doe 4 has continued serving in her post without incident. She plans to renew her contract to complete two additional years of service following the expiration of her current contract so that she can reach twenty years of service and receive retirement benefits. Under the transgender military ban, Jane Doe 4 will be forced to serve under a cloud of uncertainty about continued service, promotions, and health care; and she will suffer harm because her continued service will be permitted only under a conditional and limited exception to a policy that deems transgender people unfit for service. Jane Doe 5 has been an active duty member of the United States Air Force for nearly twenty years, serving multiple tours of duty abroad, including two in Iraq. After June 2016, in reliance on the announcement that transgender people would be permitted to serve openly, she notified her superiors that she was transgender. Under the transgender military ban, Jane Doe 5 will be forced to serve under a cloud of uncertainty about continued service, promotions, and health care; and she will suffer harm because her continued service will be permitted only under a conditional and limited exception to a policy that deems transgender people unfit for service. She has received hundreds of hours of specialized training, above the basic training required for her position, in joint target development, joint battle assessment, unmanned aerial surveillance, and computer science. She had made a behavioral health appointment to obtain a transition plan and begin her gender transition when President Trump tweeted his announcement that transgender people were no longer permitted to serve. As a result, Jane Doe 6 never came out to her doctors or chain of command as transgender. Under the transgender military ban, if Jane Doe 6 notifies her command that she is transgender and seeks health care for the distress she experiences from having to serve in a manner inconsistent with her gender identity, she faces separation from the military. She would be ineligible for a military pension and other benefits upon which she relies. A separation would also have serious negative repercussions for her career and livelihood. In addition, the transgender military ban causes Jane Doe 6 the immediate harms of curtailing her access to health care and forcing her to live inconsistently with her gender identity to avoid separation from the military. Jane Doe 7 is a transgender woman who was seeking to join the Coast Guard when the Trump administration announced its implementation plan banning service by transgender people on March 23, 2018. Under the transgender military ban, Jane Doe 7 will be unable to join the Coast Guard. She will be deprived of the opportunity to serve her country and the many benefits that enlistment in the Coast Guard would afford her. |
